TP53 and pachyonychia congenita: These models differ only in the p53 status of pancreatic epithelial cells and previous work demonstrated that mutant p53R172H in the epithelial cells drove the progression of invasive and metastatic PC over and above the effects of loss-of-p538,16–19, in agreement with observations in patients4.